Long-term safety study of iguratimod in patients with rheumatoid arthritis

Modern Rheumatology

Volumn 17, Issue 1, 2007, Pages 10-16

  Hara, Masako ^a   Abe, Tohru ^b   Sugawara, Sachiko ^a   Mizushima, Yutaka ^c   Hoshi, Keiko ^d   Irimajiri, Shoichiro ^e   Hashimoto, Hiroshi ^f   Yoshino, Shinichi ^g   Matsui, Nobuo ^h   Nobunaga, Masashi ⁱ  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^e KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^f Juntendo University Hospital   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h Nagoya City Rehabilitation Center   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

Author keywords

Disease modifying antirheumatic drug (DMARD); Iguratimod; Long term study; Rheumatoid arthritis

Indexed keywords

IGURATIMOD; ANTIRHEUMATIC AGENT; CHROMONE DERIVATIVE; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; SULFONAMIDE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BETA 2 MICROGLOBULIN URINE LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DIZZINESS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ERUPTION; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ECZEMA; EOSINOPHIL COUNT; ERYTHROCYTE COUNT; FATIGUE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL DISEASE; HEMATOCRIT; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFECTION; INTERSTITIAL LUNG DISEASE; IRON BLOOD LEVEL; JAPAN; JAPANESE; KIDNEY DISEASE; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LIVER FUNCTION; LONG TERM CARE; LOOSE FECES; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTICENTER STUDY; NAUSEA; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; OCCULT BLOOD; PLEURA EMPYEMA; PRIORITY JOURNAL; PROTEINURIA; PRURITUS; RETCHING; RHEUMATOID ARTHRITIS; RHINOPHARYNGITIS; SEPSIS; SIDE EFFECT; SKIN DISEASE; STOMACH DISCOMFORT; STOMACH PAIN; STOMACH ULCER; STOMATITIS; TASTE DISORDER; UPPER ABDOMINAL PAIN; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URINARY CAST; URINE SEDIMENT; VOMITING; DRUG ANTAGONISM; DRUG EFFECT; HOSPITALIZATION; LIVER; MIDDLE AGED; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHROMONES; CYTOKINES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SULFONAMIDES; TREATMENT OUTCOME;

EID: 34247646059     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-006-0543-x     Document Type: Article

References (15)

1. K Tanaka T Shimotori S Makino Y Aikawa T Inaba C Yoshida 1992 Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one. 1st communication: Antiinflammatory, analgesic and other related properties Arzneimittelforschung 42 935-44 1418059 1:CAS:528:DyaK38XlsVejs7c%3D
2. K Tanaka T Shimotori Y Taniguchi M Eguchi C Abe 1993 Pharmacological studies on T-614, a novel anti-inflammatory agent: Effect on type II collagen-induced arthritis in DBA/1J mice and spontaneous arthritis in MRL/l mice Int J Immunother 9 69-78 1:CAS:528:DyaK3sXmtFKqsLw%3D
3. K Tanaka T Yamamoto Y Aikawa K Kizawa K Muramoto H Matsuno 2003 Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice Rheumatology (Oxf) 42 1365-71 10.1093/rheumatology/keg381 1:CAS:528:DC%2BD3sXos1antbY%3D
4. M Kohno Y Aikawa Y Tsubouchi A Hashiramoto R Yamada Y Kawahito 2001 Inhibitory effect of T-614 on tumor necrosis factor-alpha induced cytokine production and nuclear factor-kappaB activation in cultured human synovial cells J Rheumatol 28 2591-6 11764202 1:CAS:528:DC%2BD38Xht12iuw%3D%3D
5. Y Aikawa M Yamamoto T Yamamoto K Morimoto K Tanaka 2002 An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS- and TNF-alpha-stimulated THP-1 cells without interfering with IkappaBalpha degradation Inflamm Res 51 188-94 12058956 10.1007/PL00000291 1:CAS:528:DC%2BD38XjtlWhtLc%3D
6. JC Edwards G Cambridge 2001 Sustained improvement in rheumatoid arthritis following a protocol designed to delete B lymphocytes Rheumatology (Oxf) 40 201-11
7. S De Vita F Zaja S Sacco A Dde Candia R Fanin G Ferraccioli 2002 Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis; evidence for a pathogenetic role of B cells Arthritis Rheum 46 2029-33 12209504 10.1002/art.10467 1:CAS:528:DC%2BD38XmvFOqtLw%3D
8. DT Felson JJ Anderson M Boers C Bombardier M Chernoff B Fried 1993 The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials Arthritis Rheum 36 729-40 8507213 1:STN:280:ByyB1c3os1c%3D
9. DT Felson JJ Anderson M Boers C Bombardier D Furst C Goldsmith 1995 American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum 38 727-35 7779114 1:STN:280:ByqB1MfgsFI%3D
10. T Inoue S Kawai T Azuma T Asai S Kondoh 1997 Proposed standard of clinical trial for antirheumatic drug/therapy by the Drug Evaluation Committee of Japan Rheumatism Foundation The RYUMACHI 37 516-20
11. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315-24 3358796 1:STN:280:BieC1M3nt1Q%3D
12. T Pincus JA Summey SA Soraci Jr KA Wallston NP Hummon 1983 Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire Arthritis Rheum 26 1346-53 6639693 1:STN:280:BiuD2M3mt1Q%3D
13. http://www.meddramsso.com/NewWeb2003/index.htm
14. M Hara T Abe S Sugawara M Mizushima K Hoshi S Irimajiri 2007 Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: A controlled, multicentre, double-blind, parallel-group study Modern Rheumatology 17 1-9
15. H Tateishi R Ogawa T Nakamura N Murata S Tanaka 2003 Evaluation of long-term safety and efficacy of leflunomide in Japanese patients with rheumatoid arthritis (in Japanese) J New Remedies Clinics 52 7 932